Category: St. Jude Medical
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific reveals federal probe of BridgePoint buy, sales; Court defines 'breast implant' in Dow Corning's $2B product liability saga; Apex fights to get respiratory masks back in Germany; St. Jude and Volcano call a cease-fire
St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.
St. Jude Medical puts a ribbon on its $200 million cash acquisition of radiofrequency ablation devices maker NeuroTherm.
Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.
MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.
On July 15, 2014, MassDevice.com brought together 4 senior medtech leaders to discuss the future of the medical device industry at our DeviceTalks Boston event.
Medicare regulators finalize new reimbursement coverage for Abbott's MitraClip heart valve device and St. Jude Medical's CardioMEMs heart failure monitoring system.
The Mass. Supreme Judicial Court denies St. Jude Medical's bid to overturn the portions of a lower court's ruling that went against it in its laser technology spat with Volcano Corp.
The highest court in Massachusetts largely denied
Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.
The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.